Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Renin Stories

2013-04-18 23:19:17

d´Oliveira & Associates has issued a new infographic providing information on a Tekturna medical study that was stopped due to patients suffering from nonfatal stroke, hyperkalemia, and hypotension. (PRWEB) April 18, 2013 Tekturna (aliskiren), produced by Novartis, is a once-daily pill used to treat high blood pressure (hypertension) and is the first “Renin Inhibitor” drug that regulates the renin enzyme in the kidney. This process assists by narrowing the blood...

2012-03-22 21:17:45

Drug manufacturer deviates from the appropriate comparator therapy specified by the G-BA The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care...

2011-11-09 15:30:00

The Salt Institute asks federal agencies to reverse their anti-salt agenda to protect the American public from the well-documented risk of diabetes, stroke, and heart disease that comes with the government's dangerous LOW-salt diet. Washington, DC (PRWEB) November 09, 2011 A meta-analysis published today (Nov. 9) in the American Journal of Hypertension confirms what the Salt Institute has been warning for years: -- Low-sodium diets trigger a negative chain reaction in the body that...

The Genetics Of High Blood Pressure
2011-11-09 09:20:02

Study co-authored by University of Leicester cardiovascular expert identifies key genetic mechanisms that help control blood pressure A researcher from the University of Leicester's Department of Cardiovascular Sciences has been involved in a ground-breaking study into the causes of high blood pressure. The study, published in the academic journal Hypertension, analyzed genetic material in human kidneys in a search for genes that might contribute to high blood pressure. The findings...

2011-08-11 12:08:26

Thomas Jefferson University research suggests a potential target"”Angiotensin II type 2 receptor"”for chemopreventive agents to fight pancreatic cancer Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division. With that, a new...

2011-02-25 16:03:00

DEERFIELD, Ill. and OSAKA, Japan, Feb. 25, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved EDARBI (azilsartan medoxomil) for the treatment of hypertension, or high blood pressure, in adults. EDARBI is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor...

2011-01-17 22:17:53

Scientists have identified the first DNA sequence variant common in the population that is not only associated with an increased risk of heart failure, but appears to play a role in causing it. The variant, a change in a single letter of the DNA sequence, impairs channels that control kidney function. "It's not a heart gene," says Gerald W. Dorn II, MD, the Philip and Sima K. Needleman Professor of Medicine at Washington University School of Medicine in St. Louis and a lead investigator on...

2011-01-17 12:06:24

Research offers new target for possible hypertension therapies The kidney is made up of roughly 1 million working units called nephrons. These basic structural units remove waste products from the blood, recycle some substances to be reused and eliminate what is left as urine. The end segment of nephrons, called the distal nephron, helps set blood pressure by controlling the amount of sodium in our blood. Today scientists at The University of Texas Health Science Center San Antonio reported...

2010-10-08 01:32:21

Scientists have discovered a mechanism which raises blood pressure in pre-eclampsia, a potentially deadly condition which occurs during pregnancy. After 20 years of research, scientists from the University of Cambridge have now cracked the first step in the main process that controls blood pressure. Their findings, published today in the journal Nature, are likely to have significant implications for the treatment of pre-eclampsia as well as high blood pressure (also known as hypertension)....

2010-09-28 07:00:00

BURLINGTON, Mass., Sept. 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, owing to increasing generic availability of antihypertensive agents, the hypertension drug market will decline from $26 billion in 2009 to $23 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan. The Pharmacor 2010 findings from the topic entitled Hypertension reveal that the...